Catherine Diefenbach, MD, Director, Clinical Lymphoma Program, Perlmutter Cancer Center @nyulangone discusses how combination therapies are evolving to unmet needs in follicular lymphoma.
Combination Therapies Evolving in Follicular Lymphoma
Advertisement